Geneva, Oct. 15 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134013) titled 'Efficacy and Safety of Ivarmacitinib in the Treatment of Non-Segmental Vitiligo: A 16-Week Small-Sample Real-World Study' on Oct. 10.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Huashan Hospital, Fudan University
Condition:
Vitiligo
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: 2026-04-16
Target Sample Size: Experimental group:20;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=324833
Disclaimer: Curated by HT Syndication....